# Aura Systems Inc: financial statements, quarterly AUSI · OTC · CIK 826253 · [Technology](/sectors/technology.md) · fiscal year ends Feb 28 Pages: [Overview](/companies/ausi.md) · [Financials](/companies/ausi/financials.md) · [Filings](/companies/ausi/filings.md) · [Insiders](/companies/ausi/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ausi/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2024 (2023-11-30) | period not labelled (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.0](/filings/0001213900-25-004951.md) | [(0.0) d](/filings/0001213900-25-054252.md) | [0.0](/filings/0001213900-25-066157.md) | [0.0](/filings/0001213900-25-100320.md) | [0.0 d](/filings/0001213900-26-005589.md) | [0.0 d](/filings/0001213900-26-098484.md) | [0.2](/filings/0001213900-26-102270.md) | [0.0 d](/filings/0001213900-26-111064.md) | [0.1](/filings/0001213900-26-005589.md) | [0.0 d](/filings/0001213900-26-098484.md) | [0.0](/filings/0001213900-26-102270.md) | [0.0](/filings/0001213900-26-111064.md) | | Cost of revenue | $m | [0.1](/filings/0001213900-25-004951.md) | [(0.0) d](/filings/0001213900-25-054252.md) | [0.0](/filings/0001213900-25-066157.md) | [(0.0)](/filings/0001213900-24-089379.md) | [0.0 d](/filings/0001213900-25-004951.md) | [0.0 d](/filings/0001213900-26-098484.md) | [0.0](/filings/0001213900-26-102270.md) | [0.0 d](/filings/0001213900-26-111064.md) | not reported | not reported | not reported | [0.0](/filings/0001213900-26-111064.md) | | Gross profit | $m | [(0.1)](/filings/0001213900-25-004951.md) | [0.0 d](/filings/0001213900-25-054252.md) | not reported | [0.0](/filings/0001213900-25-100320.md) | [0.0 d](/filings/0001213900-26-005589.md) | [0.0 d](/filings/0001213900-26-098484.md) | [0.2](/filings/0001213900-26-102270.md) | [0.0 d](/filings/0001213900-26-111064.md) | [0.1](/filings/0001213900-26-005589.md) | [0.0 d](/filings/0001213900-26-098484.md) | [0.0](/filings/0001213900-26-102270.md) | [0.0](/filings/0001213900-26-111064.md) | | Research and development | $m | [0.0](/filings/0001213900-25-004951.md) | [0.2 d](/filings/0001213900-25-054252.md) | [0.3](/filings/0001213900-25-066157.md) | [0.2](/filings/0001213900-25-100320.md) | [0.2](/filings/0001213900-26-005589.md) | [0.5 d](/filings/0001213900-26-098484.md) | [0.4](/filings/0001213900-26-102270.md) | [0.3](/filings/0001213900-26-111064.md) | [0.5](/filings/0001213900-26-005589.md) | [0.4 d](/filings/0001213900-26-098484.md) | [0.4](/filings/0001213900-26-102270.md) | [0.4](/filings/0001213900-26-111064.md) | | Selling, general and administrative | $m | [0.5](/filings/0001213900-25-004951.md) | [0.5 d](/filings/0001213900-25-054252.md) | [0.4](/filings/0001213900-25-066157.md) | [2.3](/filings/0001213900-25-100320.md) | [0.7](/filings/0001213900-26-005589.md) | [0.3 d](/filings/0001213900-26-098484.md) | [0.5](/filings/0001213900-26-102270.md) | [0.6](/filings/0001213900-26-111064.md) | [0.5](/filings/0001213900-26-005589.md) | [0.6 d](/filings/0001213900-26-098484.md) | [0.5](/filings/0001213900-26-102270.md) | [0.6](/filings/0001213900-26-111064.md) | | Operating income | $m | [(0.6)](/filings/0001213900-25-004951.md) | [(0.8) d](/filings/0001213900-25-054252.md) | [(0.7)](/filings/0001213900-25-066157.md) | [(2.5)](/filings/0001213900-25-100320.md) | [(0.9)](/filings/0001213900-26-005589.md) | [(0.8) d](/filings/0001213900-26-098484.md) | [(0.7)](/filings/0001213900-26-102270.md) | [(0.9)](/filings/0001213900-26-111064.md) | [(0.8)](/filings/0001213900-26-005589.md) | [(1.0) d](/filings/0001213900-26-098484.md) | [(0.9)](/filings/0001213900-26-102270.md) | [(0.9)](/filings/0001213900-26-111064.md) | | Interest expense | $m | [0.3](/filings/0001213900-25-004951.md) | [(0.1) d](/filings/0001213900-25-054252.md) | [0.3](/filings/0001213900-25-066157.md) | [0.3](/filings/0001213900-24-089379.md) | [0.5](/filings/0001213900-25-004951.md) | [0.5 d](/filings/0001213900-25-054252.md) | [0.4](/filings/0001213900-25-066157.md) | [0.7](/filings/0001213900-26-111064.md) | [0.4](/filings/0001213900-26-005589.md) | [0.6 d](/filings/0001213900-26-098484.md) | [0.5](/filings/0001213900-26-102270.md) | [0.5](/filings/0001213900-26-111064.md) | | Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net income | $m | [(0.9)](/filings/0001213900-25-004951.md) | [(1.0) d](/filings/0001213900-25-054252.md) | [(15.3)](/filings/0001213900-26-005589.md) | [(6.4)](/filings/0001213900-26-005589.md) | [(0.5)](/filings/0001213900-26-005589.md) | [1.1 d](/filings/0001213900-26-098484.md) | [(2.8)](/filings/0001213900-26-102270.md) | [(4.8)](/filings/0001213900-26-111064.md) | [5.5](/filings/0001213900-26-005589.md) | [(8.8) d](/filings/0001213900-26-098484.md) | [(8.4)](/filings/0001213900-26-102270.md) | [3.4](/filings/0001213900-26-111064.md) | | Diluted EPS | $ per share | [(0.01)](/filings/0001213900-25-004951.md) | not reported | [(0.14)](/filings/0001213900-25-066157.md) | [(0.06)](/filings/0001213900-25-100320.md) | [0.00](/filings/0001213900-26-005589.md) | not reported | [(0.02)](/filings/0001213900-26-102270.md) | [(0.04)](/filings/0001213900-26-111064.md) | [0.04](/filings/0001213900-26-005589.md) | not reported | [(0.06)](/filings/0001213900-26-102270.md) | [0.02](/filings/0001213900-26-111064.md) | | Basic EPS | $ per share | [(0.01)](/filings/0001213900-25-004951.md) | not reported | [(0.14)](/filings/0001213900-25-066157.md) | [(0.06)](/filings/0001213900-25-100320.md) | [0.00](/filings/0001213900-26-005589.md) | not reported | [(0.02)](/filings/0001213900-26-102270.md) | [(0.04)](/filings/0001213900-26-111064.md) | [0.04](/filings/0001213900-26-005589.md) | not reported | [(0.06)](/filings/0001213900-26-102270.md) | [0.02](/filings/0001213900-26-111064.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: not reported - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2024 (2023-11-30) | period not labelled (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [0.0](/filings/0001213900-24-003660.md) | [0.1](/filings/0001213900-25-054252.md) | [0.3](/filings/0001013762-24-000546.md) | [0.0](/filings/0001213900-24-089379.md) | [0.0](/filings/0001213900-25-004951.md) | [0.0](/filings/0001213900-26-098484.md) | [0.0](/filings/0001213900-25-066157.md) | [0.0](/filings/0001213900-25-100320.md) | [0.1](/filings/0001213900-26-005589.md) | [0.0](/filings/0001213900-26-098484.md) | not reported | not reported | | Current assets | $m | [0.3](/filings/0001213900-24-003660.md) | [0.3](/filings/0001213900-25-054252.md) | [0.5](/filings/0001013762-24-000546.md) | [0.1](/filings/0001213900-24-089379.md) | [0.3](/filings/0001213900-25-004951.md) | [0.3](/filings/0001213900-26-098484.md) | [0.2](/filings/0001213900-25-066157.md) | [0.1](/filings/0001213900-25-100320.md) | [0.4](/filings/0001213900-26-005589.md) | [0.2](/filings/0001213900-26-111064.md) | [0.2](/filings/0001213900-26-102270.md) | [0.1](/filings/0001213900-26-111064.md) | | Total assets | $m | [1.5](/filings/0001213900-24-003660.md) | [1.5](/filings/0001213900-25-054252.md) | [1.9](/filings/0001013762-24-000546.md) | [1.5](/filings/0001213900-24-089379.md) | [1.5](/filings/0001213900-25-004951.md) | [1.5](/filings/0001213900-26-098484.md) | [1.3](/filings/0001213900-25-066157.md) | [1.1](/filings/0001213900-25-100320.md) | [1.3](/filings/0001213900-26-005589.md) | [1.4](/filings/0001213900-26-111064.md) | [1.2](/filings/0001213900-26-102270.md) | [1.5](/filings/0001213900-26-111064.md) | | Current liabilities | $m | [14.9](/filings/0001213900-24-003660.md) | [15.2](/filings/0001213900-25-054252.md) | [28.7](/filings/0001013762-24-000546.md) | [33.4](/filings/0001213900-24-089379.md) | [32.3](/filings/0001213900-25-004951.md) | [38.4](/filings/0001213900-26-098484.md) | [40.4](/filings/0001213900-25-066157.md) | [44.3](/filings/0001213900-25-100320.md) | [37.9](/filings/0001213900-26-005589.md) | [45.4](/filings/0001213900-26-111064.md) | [54.0](/filings/0001213900-26-102270.md) | [50.7](/filings/0001213900-26-111064.md) | | Total liabilities | $m | [22.7](/filings/0001213900-24-003660.md) | [23.0](/filings/0001213900-25-054252.md) | [37.5](/filings/0001013762-24-000546.md) | [41.3](/filings/0001213900-24-089379.md) | [41.0](/filings/0001213900-25-004951.md) | [39.1](/filings/0001213900-26-098484.md) | [40.9](/filings/0001213900-25-066157.md) | [44.6](/filings/0001213900-25-100320.md) | [38.2](/filings/0001213900-26-005589.md) | [46.2](/filings/0001213900-26-111064.md) | [54.7](/filings/0001213900-26-102270.md) | [51.8](/filings/0001213900-26-111064.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [(21.2)](/filings/0001213900-25-004951.md) | [(21.5)](/filings/0001213900-26-098484.md) | [(35.6)](/filings/0001213900-26-005589.md) | [(39.8)](/filings/0001213900-26-005589.md) | [(39.5)](/filings/0001213900-26-005589.md) | [(37.6)](/filings/0001213900-26-111064.md) | [(39.6)](/filings/0001213900-26-111064.md) | [(43.5)](/filings/0001213900-26-111064.md) | [(36.9)](/filings/0001213900-26-005589.md) | [(44.8)](/filings/0001213900-26-111064.md) | [(53.6)](/filings/0001213900-26-111064.md) | [(50.3)](/filings/0001213900-26-111064.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2024 (2023-11-30) | period not labelled (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [(646) d](/filings/0001213900-25-004951.md) | [(817) d](/filings/0001213900-25-054252.md) | [(784)](/filings/0001213900-25-066157.md) | [(835) d](/filings/0001213900-25-100320.md) | [(864) d](/filings/0001213900-26-005589.md) | [(740) d](/filings/0001213900-26-098484.md) | [(746)](/filings/0001213900-26-102270.md) | [(764) d](/filings/0001213900-26-111064.md) | [(887) d](/filings/0001213900-26-005589.md) | [(1,008) d](/filings/0001213900-26-098484.md) | [(719)](/filings/0001213900-26-102270.md) | [(850) d](/filings/0001213900-26-111064.md) | | Capital expenditure | $k | not reported | [(1.0) d](/filings/0001213900-25-054252.md) | [36.0](/filings/0001213900-25-066157.md) | [31.0 d](/filings/0001213900-25-100320.md) | [0.0 d](/filings/0001213900-26-005589.md) | [36.0 d](/filings/0001213900-26-098484.md) | not reported | not reported | [8.0 d](/filings/0001213900-26-005589.md) | [(1.0) d](/filings/0001213900-26-098484.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ## Shares | Line item | Unit | Q3 FY2023 (2022-11-30) | Q1 FY2024 (2023-05-31) | Q2 FY2024 (2023-08-31) | Q3 FY2024 (2023-11-30) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [90.8](/filings/0001213900-24-003660.md) | [96.0](/filings/0001013762-24-000546.md) | [98.3](/filings/0001213900-24-089379.md) | [100](/filings/0001213900-25-004951.md) | [106](/filings/0001213900-25-066157.md) | [111](/filings/0001213900-25-100320.md) | [113](/filings/0001213900-26-005589.md) | [120](/filings/0001213900-26-102270.md) | [123](/filings/0001213900-26-111064.md) | [128](/filings/0001213900-26-005589.md) | [145](/filings/0001213900-26-102270.md) | [148](/filings/0001213900-26-111064.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 147,967,526 at 2026-08-31, from the cover of the [10-Q filed 2026-10-20](/filings/0001213900-26-111064.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.